Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)

China flag China · Delayed Price · Currency is CNY
21.21
+0.40 (1.92%)
Mar 10, 2026, 3:00 PM CST
-9.90%
Market Cap 3.55B
Revenue (ttm) 1.15B
Net Income (ttm) 136.81M
Shares Out 167.44M
EPS (ttm) 0.82
PE Ratio 25.96
Forward PE 17.14
Dividend 0.30 (1.44%)
Ex-Dividend Date Jun 11, 2025
Volume 2,570,580
Average Volume 3,192,701
Open 20.93
Previous Close 20.81
Day's Range 20.92 - 21.35
52-Week Range 20.24 - 40.19
Beta 0.75
RSI 34.43
Earnings Date Apr 25, 2026

About SHA:688687

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manuf... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 600
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688687
Full Company Profile

Financial Performance

In 2024, SHA:688687's revenue was 1.23 billion, a decrease of -12.87% compared to the previous year's 1.41 billion. Earnings were 142.37 million, an increase of 22.18%.

Financial Statements

News

There is no news available yet.